CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 74 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $16,000 | -88.1% | 60,430 | -51.5% | 0.00% | -87.5% |
| Q1 2019 | $135,000 | -25.4% | 124,643 | +19.3% | 0.01% | -33.3% |
| Q4 2018 | $181,000 | +166.2% | 104,443 | +799.4% | 0.01% | +300.0% |
| Q1 2018 | $68,000 | -73.1% | 11,613 | -86.8% | 0.00% | -75.0% |
| Q4 2015 | $253,000 | +10.0% | 88,111 | +70.1% | 0.01% | +33.3% |
| Q3 2015 | $230,000 | -41.9% | 51,811 | -32.8% | 0.01% | -30.8% |
| Q2 2015 | $396,000 | -44.0% | 77,058 | -22.5% | 0.01% | -45.8% |
| Q1 2015 | $707,000 | – | 99,433 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |